Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension
Saudi Journal of Kidney Diseases and Transplantation, 2011 To determine the antihypertensive benefit of adding low dose sprinolactone to multi-drug regimens that included a diuretic, a calcium channel blocker and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with moderately ...
Rozita Abolghasmi, Omolbanin Taziki
doaj
Treatment of focal junctional tachycardia using ivabradine in a dog
Veterinary Record Case Reports, EarlyView.Abstract A 10‐year‐old labrador retriever was referred as an emergency due to ascites and lethargy. Physical examination revealed a regular tachycardia at 160 beats per minute with a Grade 3/6, left apical systolic heart murmur. The dog was diagnosed with severe myxomatous mitral valve disease with biventricular congestive heart failure (mild pulmonary
Joao Escalda +2 more
wiley +1 more source
Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy [PDF]
, 2015 Introduction: Inhibitors of the renin-angiotensin aldosterone system (RAAS) are the basic drugs for treatment of diabetic nephropathy, as to some extent is spironolactone.
Behradmanesh, Mohammad Saeed +3 more
core
Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study. [PDF]
, 1980 Bengt Scherstén +7 more
openalex +1 more source
Prevention of Post‐Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review
Australasian Journal of Dermatology, Volume 66, Issue 3, Page 119-126, May 2025.ABSTRACT Background/Objectives Post‐inflammatory hyperpigmentation (PIH) impacts all skin tones with a heightened predilection for Fitzpatrick skin types (FST) III‐VI. Preventative measures include pre‐ and post‐intervention approaches, such as sunscreen and corticosteroids. This systematic review aims to summarise the preventative measure outcomes for
Kristie Mar +5 more
wiley +1 more source
Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects. [PDF]
, 1984 Millar Ja +5 more
openalex +1 more source
Andrology, EarlyView.Abstract Background Higher muscle strength is associated with improved overall health and lower mortality. Muscle strength changes during gender‐affirming hormone therapy is possibly linked to gender‐affirming hormone therapy modality, age at initiation, gender‐affirming hormone therapy duration, and physical activity.
Mathilde Kamp Nørlund +7 more
wiley +1 more source
The effect of spironolactone on the liver microsomal enzyme system in patients. [PDF]
, 1984 E. E. Ohnhaus, E. Gerber-Taras
openalex +1 more source
Acta Paediatrica, EarlyView.ABSTRACT Aim To assess the prevalence of endocrine disorders and investigate growth patterns in single large‐scale mitochondrial DNA deletion syndromes (SLSMDs). Methods A retrospective study of all children with SLSMD who attended Sheba Medical Center, Israel, from February 2017 to September 2024.
Ayman Daka +7 more
wiley +1 more source
Fracture Risk in Men With Congestive Heart Failure Risk Reduction With Spironolactone [PDF]
ObjectivesThe purpose of this study was to determine whether spironolactone use is associated with fractures in men with congestive heart failure (CHF).BackgroundIn rats with aldosteronism, spironolactone preserves skeletal strength.
Ahmad, Khurram +19 more
core +1 more source